• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JNK信号通路在膀胱癌中的作用。

Role of the JNK Pathway in Bladder Cancer.

作者信息

Lee Eun Hye, Kim Hyun Tae, Chun So Young, Chung Jae-Wook, Choi Seock Hwan, Lee Jun Nyung, Kim Bum Soo, Yoo Eun Sang, Kwon Tae Gyun, Kim Tae-Hwan, Ha Yun-Sok

机构信息

Joint Institution of Regenerative Medicine, Kyungpook National University, Daegu, Korea.

Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.

出版信息

Onco Targets Ther. 2022 Sep 5;15:963-971. doi: 10.2147/OTT.S374908. eCollection 2022.

DOI:10.2147/OTT.S374908
PMID:36091874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9462548/
Abstract

Bladder cancer, one of the most frequently diagnosed cancers worldwide, is associated with high morbidity and mortality and a poor prognosis. The bladder cancer types include 1) non-muscle invasive bladder cancer (NMIBC) and 2) muscle invasive bladder cancer (MIBC). Metastases and chemoresistance in MIBC patients are the leading causes of the high death rate. c-Jun N-terminal kinase (JNK) is an important factor for the undifferentiated state of cancer cells. JNK belongs to the mitogen-activated protein kinases (MAPKs) family; it is activated by various extracellular stimuli, such as stress, radiation, and growth factors and mediates diverse cellular functions, such as apoptosis, autophagy, proliferation, invasion, and migration by mediating AKT (Ak strain transforming), ATG (Autophagy related), mTOR (Mammalian target of rapamycin), and caspases 3, 8, and 9. This review describes the JNK-related functions, mechanisms, and signaling in bladder cancer.

摘要

膀胱癌是全球最常被诊断出的癌症之一,其发病率和死亡率高,预后较差。膀胱癌类型包括1)非肌层浸润性膀胱癌(NMIBC)和2)肌层浸润性膀胱癌(MIBC)。MIBC患者的转移和化疗耐药是高死亡率的主要原因。c-Jun氨基末端激酶(JNK)是癌细胞未分化状态的一个重要因素。JNK属于丝裂原活化蛋白激酶(MAPKs)家族;它被各种细胞外刺激激活,如应激、辐射和生长因子,并通过介导AKT(Ak株转化)、ATG(自噬相关)、mTOR(雷帕霉素哺乳动物靶点)以及半胱天冬酶3、8和9来介导多种细胞功能,如凋亡、自噬、增殖、侵袭和迁移。本综述描述了JNK在膀胱癌中的相关功能、机制和信号传导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/9462548/caaf4ebde749/OTT-15-963-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/9462548/caaf4ebde749/OTT-15-963-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/9462548/caaf4ebde749/OTT-15-963-g0001.jpg

相似文献

1
Role of the JNK Pathway in Bladder Cancer.JNK信号通路在膀胱癌中的作用。
Onco Targets Ther. 2022 Sep 5;15:963-971. doi: 10.2147/OTT.S374908. eCollection 2022.
2
Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.Actein通过增强ROS/JNK和抑制AKT信号通路诱导人膀胱癌细胞自噬和凋亡。
Oncotarget. 2017 Nov 1;8(68):112498-112515. doi: 10.18632/oncotarget.22274. eCollection 2017 Dec 22.
3
Stress-activated kinase pathway alteration is a frequent event in bladder cancer.应激激活激酶通路改变是膀胱癌的常见事件。
Urol Oncol. 2012 Jul-Aug;30(4):415-20. doi: 10.1016/j.urolonc.2010.03.002. Epub 2011 Dec 11.
4
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.异常蛋白质糖基化与激活的PI3K/Akt/mTOR信号通路:在膀胱癌预后及靶向治疗中的作用
PLoS One. 2015 Nov 16;10(11):e0141253. doi: 10.1371/journal.pone.0141253. eCollection 2015.
5
Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.二烯丙基三硫化物诱导膀胱癌细胞凋亡是半胱天冬酶依赖性的,并受PI3K/Akt和JNK信号通路调控。
Environ Toxicol Pharmacol. 2014 Jan;37(1):74-83. doi: 10.1016/j.etap.2013.11.002. Epub 2013 Nov 9.
6
HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.高迁移率族蛋白B1(HMGB1)介导的自噬通过激活JNK和ERK减轻吉西他滨诱导的膀胱癌细胞凋亡。
Oncotarget. 2017 May 11;8(42):71642-71656. doi: 10.18632/oncotarget.17796. eCollection 2017 Sep 22.
7
Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway.黄连解毒汤通过 MAPK-mTOR 信号通路诱导脑缺血/再灌注损伤的保护性自噬。
J Ethnopharmacol. 2013 Aug 26;149(1):270-80. doi: 10.1016/j.jep.2013.06.035. Epub 2013 Jun 28.
8
A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.阿魏酸衍生物 FXS-3 通过激活 JNK 信号通路和抑制 ERK/p38、AKT/mTOR 和 MEK/ERK 信号通路抑制人肺癌 A549 细胞的增殖和转移。
Molecules. 2019 Jun 8;24(11):2165. doi: 10.3390/molecules24112165.
9
Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.非肌肉浸润性膀胱癌和肌肉浸润性膀胱癌预后和差异表达基因的比较生物信息学分析。
J Proteomics. 2020 Oct 30;229:103951. doi: 10.1016/j.jprot.2020.103951. Epub 2020 Aug 27.
10
Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.法尼基二氢黄酮 R 通过 JNK/c-Jun 信号通路诱导非小细胞肺癌 A549 细胞自噬。
Anticancer Agents Med Chem. 2020;20(8):982-988. doi: 10.2174/1871520620666200414095828.

引用本文的文献

1
WWP1 mediates the ubiquitination and degradation of HIPK3 in bladder cancer cells.WWP1介导膀胱癌细胞中HIPK3的泛素化和降解。
J Biol Chem. 2025 Apr 23;301(6):108528. doi: 10.1016/j.jbc.2025.108528.
2
Current and future perspectives on the regulation and functions of miR-545 in cancer development.miR-545在癌症发展中的调控作用及功能的当前与未来展望
Cancer Pathog Ther. 2023 Sep 5;2(3):142-154. doi: 10.1016/j.cpt.2023.09.001. eCollection 2024 Jul.
3
Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.

本文引用的文献

1
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.JNK 信号通路通过调控 METTL3 介导的 PD-L1 mRNA m6A 修饰促进膀胱癌免疫逃逸。
Cancer Res. 2022 May 3;82(9):1789-1802. doi: 10.1158/0008-5472.CAN-21-1323.
2
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.膀胱癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Mar;33(3):244-258. doi: 10.1016/j.annonc.2021.11.012. Epub 2021 Nov 30.
3
Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary History.
揭示 RAC3 在顺铂耐药膀胱癌细胞生长和侵袭中的作用。
J Cell Mol Med. 2024 Jun;28(11):e18473. doi: 10.1111/jcmm.18473.
4
USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.USP5通过稳定c-Jun蛋白促进膀胱癌进展。
Cancer Cell Int. 2024 Jan 16;24(1):32. doi: 10.1186/s12935-024-03222-7.
5
TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance.TRAF4 介导的泛素化依赖性 JNK/Bcl-xL 激活促进了放射抵抗性。
Cell Death Dis. 2023 Feb 10;14(2):102. doi: 10.1038/s41419-023-05637-y.
泌尿肿瘤学:研讨会和原始研究。二十五周年历史。
Urol Oncol. 2021 Sep;39(9):506-513. doi: 10.1016/j.urolonc.2021.01.024. Epub 2021 Feb 19.
4
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
5
Advances in bladder cancer biology and therapy.膀胱癌生物学和治疗的进展。
Nat Rev Cancer. 2021 Feb;21(2):104-121. doi: 10.1038/s41568-020-00313-1. Epub 2020 Dec 2.
6
Treatment of muscle-invasive and advanced bladder cancer in 2020.2020 年肌层浸润性和晚期膀胱癌的治疗。
CA Cancer J Clin. 2020 Sep;70(5):404-423. doi: 10.3322/caac.21631. Epub 2020 Aug 7.
7
Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancer.改良根治性前列腺切除术治疗高级别前列腺癌尿失禁的疗效。
Minerva Urol Nefrol. 2020 Oct;72(5):605-614. doi: 10.23736/S0393-2249.20.03633-4. Epub 2020 Apr 16.
8
JMJD6-STAT3 axis promotes autophagy in osteosarcoma cancer cells by regulating ATG.JMJD6-STAT3 轴通过调控 ATG 促进骨肉瘤癌细胞自噬。
Biofactors. 2020 Sep;46(5):839-848. doi: 10.1002/biof.1614. Epub 2020 Jan 20.
9
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.欧洲泌尿外科学会非肌肉浸润性膀胱癌(TaT1 和原位癌)指南 - 2019 年更新版。
Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20.
10
MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.MEX3C通过JNK信号通路调节脂质代谢以促进膀胱肿瘤发生。
Onco Targets Ther. 2019 May 1;12:3285-3294. doi: 10.2147/OTT.S199667. eCollection 2019.